Interpretation of Chinese expert consensus on the diagnosis and treatment of IgG4-related diseases
10.3969/j.issn.1001-5256.2021.09.012
- VernacularTitle:《IgG4相关性疾病诊治中国专家共识》解读
- Author:
Jiaxin ZHOU
1
;
Wen ZHANG
1
Author Information
1. National Clinical Research Center for Dermatologic and Immunologic Diseases, Key Laboratory of Ministry of Education, National Key Laboratory of Difficult Severe Diseases and Rare Diseases, Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
- Publication Type:Guideline Interpretation
- Keywords:
Immunoglobulin G;
Diagnosis;
Therapeutics;
Consensus
- From:
Journal of Clinical Hepatology
2021;37(9):2062-2065
- CountryChina
- Language:Chinese
-
Abstract:
IgG4-related disease (IgG4-RD) is an immune-mediated disease characterized by chronic inflammation and fibrosis of affected organs. With a deeper understanding of this disease among Chinese scholars and the rich experience in diagnosis and treatment in recent years, an expert group was organized by China Alliance for Rare Diseases and Chinese Rheumatology Association in 2020 and developed the first Chinese expert consensus on the diagnosis and treatment of IgG4-related diseases. This consensus comprehensively summarizes the principles of the diagnosis and treatment of IgG4-RD and thus provides a basis for its diagnosis and treatment by clinicians.
